ALNY

Alnylam Pharmaceuticals, Inc. (ALNY)

Last Price$238.0(1.1%)
Market Cap$30.1B
LTM Gross margin
85.4%
5Y avg
84.6%
Biotechnology industry median
65.9%
Stock quality & Intrinsic value
6/10
(0.6%) overvalued

Alnylam Pharmaceuticals, Inc. Gross margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
ALNY
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Gross margin
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
85.1%
97.6%
88.6%
84.2%
83.4%
83.7%
83.0%
ALNY
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for ALNY and see if it's the right time to invest.
Dive in

Alnylam Pharmaceuticals, Inc. (ALNY) Gross margin comparison analysis

Crunching data... Almost there!

ALNY key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Alnylam Pharmaceuticals, Inc.'s Gross margin?

As of today, Microsoft Corp's last 12-month Gross margin is 85.4%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Gross margin for Alnylam Pharmaceuticals, Inc. have been 83.7% over the past three years, and 88.8% over the past five years.

2) Is Alnylam Pharmaceuticals, Inc.'s Gross margin Good?

As of today, Alnylam Pharmaceuticals, Inc.'s Gross margin is 85.4%, which is higher than industry median of 65.9%. It indicates that Alnylam Pharmaceuticals, Inc.'s Gross margin is Good.

3) How does Alnylam Pharmaceuticals, Inc.'s Gross margin compare to its peers?

As of today, Alnylam Pharmaceuticals, Inc.'s Gross margin is 85.4%, which is lower than peer median of 85.4%. The list of peers includes GMAB, INCY, UTHR, ARGX, VRTX, NVO, REGN, BNTX, BGNE, MRNA.